Circulating monocyte chemotactic protein 1 (MCP-1), vascular cell adhesion molecule 1 (VCAM-1) and angiogenin in type 2 diabetic patients treated with statins in low doses

European Journal of Pharmacology

Volumn 740, Issue , 2014, Pages 474-479

  Dworacka, Marzena ^a   Krzyzagórska, Ewa ^b   Wesołowska, Anna ^a   Zharmakhanova, Gulmira ^c   Iskakova, Saule ^c   Dworacki, Grzegorz ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Poznan Specialist Center of Medical Care   (Poland)

^c WEST KAZAKHSTAN MARAT OSPANOV STATE MEDICAL UNIVERSITY   (Kazakhstan)

Author keywords

Angiogenesis; Angiogenin; MCP 1; Statins; Type 2 diabetes; VCAM 1

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOGENIN; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; METFORMIN; MONOCYTE CHEMOTACTIC PROTEIN 1; SARTAN DERIVATIVE; SIMVASTATIN; VASCULAR CELL ADHESION MOLECULE 1; ANTIDIABETIC AGENT; CCL2 PROTEIN, HUMAN; PANCREATIC RIBONUCLEASE;

ADULT; AGED; ANALYSIS OF COVARIANCE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC PATIENT; DISEASE DURATION; DRUG USE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LOW DRUG DOSE; MALE; METABOLIC PARAMETERS; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; BLOOD; CONTROLLED CLINICAL TRIAL; DIABETES MELLITUS, TYPE 2; MIDDLE AGED;

AGED; CHEMOKINE CCL2; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; RIBONUCLEASE, PANCREATIC; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84919452652     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.06.041     Document Type: Article

References (50)

1. J. Asai, H. Takenaka, S. Hirakawa, J. Sakabe, A. Hagura, S. Kishimoto, K. Maruyama, K. Kajiya, S. Kinoshita, Y. Tokura, and N. Katoh Topical simvastatin accelerates wound healing in diabetes by enhancing angiogenesis and lymphangiogenesis Am. J. Pathol. 6 2012 2217 2224 10.1016/j.ajpath.2012.08.023
2. P. Aukrust, R.K. Berge, T. Ueland, E. Aaser, J.K. Damås, L. Wikeby, A. Brunsvig, F. Müller, K. Forfang, S.S. Frøland, and L. Gullestad Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes J. Am. Coll. Cardiol. 2 2001 485 491 10.1016/S0735-1097(00)01110-4
3. H. Beekhuizen, and R. van Furth Monocyte adherence to human vascular endothelium J Leukoc. Biol. 54 1993 363 378
4. S. Bellosta, R. Paoletti, and A. Corsini Safety of statins: focus on clinical pharmacokinetics and drug interactions Circulation 109 23 Suppl 1 2004 SIII50 SIII57 10.1161/01.CIR.0000131519.15067.1f
5. L. Benjamin Glucose, VEGF-A, and diabetic complications Am. J. Pathol. 4 2001 1181 1184 10.1016/S0002-9440(10)64066-7
6. L.M. Blanco-Colio, J.L. Martín-Ventura, E. de Teresa, C. Farsang, A. Gaw, G. Gensini, L.A. Leiter, A. Langer, P. Martineau, J. Egido ACTFAST investigators Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a sub-study of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration Am. Heart J. 5 2007 881 888 10.1016/j.ahj.2007.02.029
7. H. Cakmak, M. Basar, Y. Seval-Celik, K.G. Osteen, A.J. Duleba, H.S. Taylor, C.J. Lockwood, and A. Arici Statins inhibit monocyte chemotactic protein 1 expression in endometriosis Reprod. Sci. 6 2012 572 579 10.1177/1933719111430998
8. C.-H. Chen, and J.P. Walterscheid Plaque angiogenesis versus compensatory arteriogenesis in atherosclerosis Circ. Res. 99 2006 787 789 10.1161/01.RES.0000247758.34085.a6
9. D.D. Cilla Jr.; L.R. Whitfield, D.M. Gibson, A.J. Sedman, and E.L. Posvar Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects Clin. Pharmacol. Ther. 6 1996 687 695 10.1016/S0009-9236(96)90218-0
10. M. Dworacka, H. Winiarska, M. Szymanska, S. Kuczynski, K. Szczawinska, and B. Wierusz-Wysocka 1,5-Anhydro-d-glucitol: a novel marker of glucose excursions Int. J. Clin. Pract. Suppl. 129 2002 40 44
11. M. Dworacka, and H. Winiarska The application of plasma 1,5-anhydro-d-glucitol (1,5-AG) for monitoring type 2 diabetic patients Dis. Markers 21 2005 127 132 10.1155/2005/251068
12. M. Dworacka, E. Krzyzagórska, A. Wesołowska, M. Borowska, S. Iskakova, and G. Dworacki Statins in low doses reduce VEGF and bFGF serum levels in patients with type 2 diabetes mellitus Pharmacology 93 1-2 2014 32 38 10.1159/000357476
13. B. Garmy-Susini, H. Jin, Y. Zhu, R.J. Sung, R. Hwang, and J. Varner Integrin alpha4beta1-VCAM-1-mediated adhesion between endothelial and mural cells is required for blood vessel maturation J. Clin. Invest. 115 6 2005 1542 1551 10.1172/JCI23445
14. J.E. Gerich Clinical significance, pathogenesis, and management of postprandial hyperglycemia Arch. Intern. Med. 11 2003 1306 1316 10.1001/archinte.163.11.1306
15. G.F. Hu, and J.F. Riordan Angiogenin enhances actin acceleration of plasminogen activation Biochem. Biophys. Res. Commun. 197 1993 682 687 10.1006/bbrc.1993.2533
16. Z. Hu, F. Zhang, Z. Yang, N. Yang, D. Zhang, J. Zhang, and K. Cao Combination of simvastatin administration and EPC transplantation enhances angiogenesis and protects against apoptosis for hindlimb ischemia J. Biomed. Sci. 4 2008 509 517 10.1007/s11373-008-9243-1
17. K. Kishimoto, S. Liu, T. Tsuji, K.A. Olson, and G.F. Hu Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis Oncogene 24 2005 445 456 10.1038/sj.onc.1208223
18. A.E. Koch, M.M. Halloran, C.J. Haskell, M.R. Shah, and P.J. Polverini Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1 Nature 376 1995 517 519 10.1038/376517a0
19. Y. Kureishi, Z. Luo, I. Shiojima, A. Bialik, D. Fulton, D.J. Lefer, W.C. Sessa, and K. Walsh The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals Nat. Med. 9 2000 1004 1010 10.1038/79510
20. W.W. Lee, and R.M. Galbraith The extracellular actin-scavenger system and actin toxicity N. Engl. J. Med. 326 1992 1335 1341 10.1056/NEJM199205143262006
21. Y. Lin, S. Ye, Y. Chen, X. Li, G.W. Yang, A. Fan, and Y. Wang The effect of simvastatin on the serum monocyte chemoattractant protein-1 and intracellular adhesion molecule-1 levels in diabetic rats J. Diabetes Complicat. 23 3 2009 214 218 10.1016/j.jdiacomp.2007.09.003
22. A.J. Littler, C.D. Buckley, P. Wordsworth, I. Collins, J. Martinson, and D.L. Simmons A distinct profile of six soluble adhesion molecules (ICAM-1, ICAM-3, VCAM-1, E-selectin, L-selectin, and P-selectin) in rheumatoid arthritis Br. J. Rheumatol. 36 1997 164 169
23. M. Massaro, A. Zampolli, E. Scoditti, M.A. Carluccio, C. Storelli, A. Distante, and R. De Caterina Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability Cardiovasc. Res. 2 2010 311 320 10.1093/cvr/cvp375
24. M. Milkiewicz, E. Ispanovic, J.L. Doyle, and T.L. Haas Regulators of angiogenesis and strategies for their therapeutic manipulation Int. J. Biochem. Cell Biol. 3 2006 333 357 10.1016/j.biocel.2005.10.006
25. F. Montecucco, F. Burger, G. Pelli, N.K. Poku, C. Berlier, S. Steffens, and F. Mach Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes Rheumatology 48 2009 233 242 10.1093/rheumatology/ken466
26. E. Morgan, R. Varro, H. Sepulveda, J.A. Ember, J. Apgar, J. Wilson, L. Lowe, R. Chen, L. Shivraj, A. Agadir, R. Campos, D. Ernst, and A. Gaur Cytometric bead array: a multiplexed assay platform with applications in various areas of biology Clin. Immunol. 3 2004 252 266 10.1016/j.clim.2003.11.017
27. H. Niiyama, H. Kai, T. Yamamoto, T. Shimada, K. Sasaki, T. Murohara, K. Egashira, and T. Imaizumi Roles of endogenous monocyte chemoattractant protein-1 in ischemia-induced neovascularization J. Am. Coll. Cardiol. 3 2004 661 666 10.1016/j.jacc.2004.04.046
28. J. Niu, and P. Kolattukudy Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications Clin. Sci. 117 2009 95 109 10.1042/CS20080581
29. K.D. O'Brien, M.D. Allen, T.O. McDonald, A. Chait, J.M. Harlan, D. Fishbein, J. McCarty, M. Ferguson, K. Hudkins, and C.D. Benjamin Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques: implications for the mode of progression of advanced coronary atherosclerosis J. Clin. Invest. 92 1993 945 951 10.1172/JCI116670
30. J. Panee Monocyte chemoattractant protein 1 (MCP-1) in obesity and diabetes Cytokine 1 2012 1 12 10.1016/j.cyto.2012.06.018
31. S.W. Rabkin, A. Langer, E. Ur, C.D. Calciu, and L.A. Leiter Inflammatory biomarkers CRP, MCP-1, serum amyloid alpha and interleukin-18 in patients with HTN and dyslipidemia: impact of diabetes mellitus on metabolic syndrome and the effect of statin therapy Hypertens. Res. 36 6 2013 550 558 10.1038/hr.2012.214
32. K. Ray, and C. Cannon The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the mangement of acute coronary syndromes J. Am. Coll. Cardiol. 8 2005 1425 1433 10.1016/j.jacc.2005.05.086
33. A. Riad, J. Du, S. Stiehl, D. Westermann, Z. Mohr, M. Sobirey, W. Doehner, V. Adams, M. Pauschinger, H.P. Schultheiss, and C. Tschöpe Low-dose treatment with atorvastatin leads to anti-oxidative and anti-inflammatory effects in diabetes mellitus Eur. J. Pharmacol. 569 3 2007 204 211 10.1016/j.ejphar.2007.04.065
34. S.K. Saxena, S.M. Rybak, R.T. Davey Jr.; R.J. Youle, and E.J. Ackerman Angiogenin is a cytotoxic, tRNA-specific ribonuclease in the RNase A superfamily J. Biol. Chem. 30 1992 21982 21986
35. S. Shimoyama, and M. Kaminishi Angiogenin in sera as an independent prognostic factor in gastric cancer J. Cancer Res. Clin. Oncol. 129 2003 239 244 10.1007/s00432-003-0422-1
36. J. Siebert, M. Reiwer-Gostomska, J. Mysliwska, N. Marek, K. Raczynska, and L. Glasner Glycemic control influences serum angiogenin concentrations in patients with type 2 diabetes Diabetes Care 8 2010 1829 1830 10.2337/dc10-0130
37. M. Simons Angiogenesis, arteriogenesis, and diabetes: paradigm reassessed? J. Am. Coll. Cardiol. 5 2005 835 837 10.1016/j.jacc.2005.06.008
38. A. Skaletz-Rorowski, and K. Walsh Statin therapy and angiogenesis Curr. Opin. Lipidol. 6 2003 599 603
39. A. Tello-Montoliu, F. Marín, J. Patel, V. Roldán, L. Mainar, V. Vicente, F. Sogorb, and G.Y. Lip Plasma angiogenin levels in acute coronary syndromes:implications for prognosis Eur. Heart J. 28 2007 3006 3011 10.1093/eurheartj/ehm488
40. A. Tello-Montoliu, J.V. Patel, and G.Y. Lip Angiogenin: a review of the pathophysiology and potential clinical applications J. Thromb. Haemost. 4 2006 1864 1874 10.1111/j.1538-7836.2006.01995.x
41. The American Diabetes Association Standards of medical care in diabetes Diabetes Care 30 Suppl 1 2007 S4 S41 (doi: 10.2337/dc07-S004)
42. The European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary (The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J. 1 2007 88 136 (doi: 10.1093/eurheartj/ehl260)
43. C. Urbich, E. Dernbach, A.M. Zeiher, and S. Dimmeler Double-edge role of statins in angiogenesis signaling Circ. Res. 90 2002 737 744 10.1161/01/RES0000014081.30867.F8
44. N.R. Veillard, V. Braunersreuther, C. Arnaud, F. Burger, G. Pelli, S. Steffens, and F. Mach Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages Atherosclerosis 188 1 2006 51 58 10.1016/j.atherosclerosis.2005.10.015
45. A.M. Wägner, J.L. Sánchez-Quesada, S. Benítez, C. Bancells, J. Ordóñez-Llanos, and A. Pérez Effect of statin and fibrate treatment on inflammation in type 2 diabetes. A randomized, cross-over study Diabetes Res. Clin. Pract. 93 1 2011 e25 e28 10.1016/j.diabres.2011.03.009
46. C.-Y. Wang, P.Y. Liu, and J.K. Liao Pleiotropic effects of statin therapy: molecular mechanisms and clinical results Trends Mol. Med. 1 2008 37 44 10.1016/j.molmed.2007.11.004
47. M. Weis, C. Heeschen, A.J. Glassford, and J.P. Cooke Statins have biphasic effects on angiogenesis Circulation 105 2002 739 745 10.1161/hc0602.103393
48. C. Weykamp, W.G. John, A. Mosca, T. Hoshino, R. Little, J.O. Jeppsson, I. Goodall, K. Miedema, G. Myers, H. Reinauer, D.B. Sacks, R. Slingerland, and C. Siebelder The IFCC reference measurement system for HbA1c: a 6-year progress report Clin. Chem. 2 2008 240 248 10.1373/clinchem.2007.097402
49. T. Yamanouchi, Y. Tachibana, H. Akanuma, S. Minoda, T. Shinohara, H. Moromizato, H. Miyashita, and I. Akaoka Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body Am. J. Physiol. 263 1992 E268 E273
50. X.Y. Zhu, E. Daghini, A.R. Chade, R. Lavi, C. Napoli, A. Lerman, and L.O. Lerman Disparate effects of simvastatin on angiogenesis during hypoxia and inflammation Life Sci. 83 23-24 2008 801 809 10.1016/j.lfs.2008.09.029